Jointown Pharmaceutical Group Co Ltd (600998) — Capital Reinvestment Ratio
Jointown Pharmaceutical Group Co Ltd (600998) has a Capital Reinvestment Ratio of 0.53x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥528.22 Million) in capital expenditures (CN¥281.66 Million). See 600998 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jointown Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2007–2024)
This chart tracks Jointown Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Jointown Pharmaceutical Group Co Ltd (2007–2024)
Year-by-year Capital Reinvestment Ratio for Jointown Pharmaceutical Group Co Ltd from 2007 to 2024. For live market cap and broader valuation context, see market value of Jointown Pharmaceutical Group Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥3.08 Billion | CN¥975.42 Million | ▲ +44.3% |
| 2023 | 0.22x | CN¥4.78 Billion | CN¥1.05 Billion | ▼ -29.7% |
| 2022 | 0.31x | CN¥3.99 Billion | CN¥1.24 Billion | ▼ -22.2% |
| 2021 | 0.40x | CN¥3.46 Billion | CN¥1.39 Billion | ▼ -5.3% |
| 2020 | 0.42x | CN¥3.44 Billion | CN¥1.46 Billion | ▼ -1.8% |
| 2019 | 0.43x | CN¥2.77 Billion | CN¥1.19 Billion | ▼ -71.0% |
| 2018 | 1.49x | CN¥1.22 Billion | CN¥1.81 Billion | ▼ -44.3% |
| 2016 | 2.67x | CN¥431.26 Million | CN¥1.15 Billion | ▲ +15.3% |
| 2015 | 2.31x | CN¥435.96 Million | CN¥1.01 Billion | ▼ -47.8% |
| 2013 | 4.43x | CN¥138.47 Million | CN¥613.81 Million | ▲ +596.5% |
| 2008 | 0.64x | CN¥494.75 Million | CN¥314.90 Million | ▼ -85.7% |
| 2007 | 4.44x | CN¥65.95 Million | CN¥293.03 Million | — |